Drug Profile
Ciclopirox topical - Acrux
Alternative Names: Ciclopirox MDTSLatest Information Update: 18 Aug 2009
Price :
$50
*
At a glance
- Originator Acrux
- Class Antifungals; Proteins; Pyridones; Small molecules
- Mechanism of Action Mitosis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Onychomycosis
Most Recent Events
- 23 May 2005 Acrux and Napa Biosciences have entered into an exclusive worldwide licensing agreement to develop and commercialise certain prescription and over-the-counter dermatology products for various skin disorders, including onychomycosis
- 23 May 2005 Preclinical trials in Onychomycosis in USA (Topical)
- 12 Jul 2004 Ciclopirox topical is available for licensing (http://www.acrux.com.au)